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INTRODUCTION

Monoamine Oxidase

(MAO)

has proven to be most problematic

for both basic scientists and clinicians.
literature is organized

The review of the

in'terms of the techniques used to

elucidate the molecular basis of MAO's activity,
some understanding can be distilled

hoping that

from an extensive and

conflicting research history,
I would like to acknowledge the help offered to me by
Dr,

Gerry Young,

Kavanaugh,

Norman Gillls and Mary Ellen

Their concern was appreciated,

ind ispensible.
gratitude.

Professor C.

For Donald Cohen,

For me,

their good

spirits

I have the pro found est • v • -:

the most Important aspects of the past:

year in research had
as Donald well knows.

little to do with laboratories and
Finally,

platelets

I thank my wife for her love

manifest in her endurance that supported me during this work.

PHARMACOLOGY OF KAO

Neuropsychiatric

interest in Monoamine Oxidase

(MO,

EC 1,4.3.4.) was stimulated by several major findings in
the 1950’s.

Zeller discovered that iproniazid, an anti**

tuberculosis agent, was a potent in vitro and
inhibitor of MO.

In vivo

During the same period, Amin,

Vogt and

Bertler found that Serotonin (5-HT), Norepinephrine
and Dopamine

(NE),

(DA), all substrates for MAO, were distlbuted

in the brain.
Clinically it had been noted that tuberculous patients
treated with iproniazid experienced a lightening of their
mood.

This observation led Loomer and Saunders to.introduce

iproniazid for the treatment of depression.
groundwork was laid for the

Thus the

"catecholamine hypothesis" of

affective disorders postulated

by Schildkraut and Kety in

1965.
During the 1960"s,

the investigation of KAO inhibitors

was remarkable for the repeated
could

finding that the substrate

influence the activity of the

in inhibition kinetics,

pH optima,

Inhibitor.

Differences

Michaelis constants,

ion effects and substrate inhibition suggested the presence
of either multiple enzymes or one enzyme with multiple
catalytic sites.

Since all the work was done with reversible

Inhibitors on non-purifled

enzyme preparations,

it was not

possible to rule out steric factors as an explanation,
in addition,

no Inhibitor was found

to selectively inhibit

KAO activity to one substrate and not another.(for review,
see Achee,

Gabay and Tipton,

1977; Youdlm & Collins,

1975)

(2)

Johnston,

In 1968,

Introduced clorgyline as an irrever¬

sible inhibitor of MAO prepared

from rat brain

(Johnston,

1968). The concentration of drug required to inhibit the
oxidation of 5~HT was several orders of magnitude less
than that necessary to inhibit benzylamine

(BZ)

oxidation.

Of most significance was the effect of clorgyline on
tyramine

(TYR)

oxidation.

toward TYR was Inhibited

Only about half of the MAO activity
by clorgyline concentrations Com--

jpl&teiy Inhibitory of 5-HT oxidation. The rest was inhibited
at concentrations necessary to stop BZ oxidation. This
bi-phasic dose-response curve, with a plateau at medium
inhibitor concentrations

(Fig,

1),

led

Johnston to postulate

the presence of two distinct enzyme species.
sensitive and

the other clorgyline resistant, designated

Type A and Type B respectively.
substrate for Type A and
& Parsons,

One clorgyline

5"HT was the preferred

BZ preferred

for Type B (Hall, Logan

1969)» with TYR a common substrate.

Fig. 1
(Fowler,

o- 5-HT
a- TYR
9 - BZ

et. al.,

1978)

(3)

Since Johnston's report,
have been introduced.
clorgyline,

other irreversible inhibitors

Some have characteristics resembling

while others selectively inhibit Type B MAO.

Most notable of the later are Deprenyl
and Pargyline

(Puller,

(Knoll & Magyar,1972)

1970).

Johnston's work serves as the paradigm for studying the
selectivity of MAO inhibitors and the proportions of MAO
types in various organs from various species, always
extrapolating from data on rat brain and liver.

Selectivity

experiments are performed assuming 5-HT oxidation to be
exclusively by Type A and BZ oxidation by Type B,

If an

inhibitor shows concentration differences In its inhibition
of 5-HT versus BZ oxidation,

it

is assigned a Type A or B

selectivity depending upon which substrate is Inhibited
by the lower concentration.

Many of the reports on the

selectivity of reversible inhibitors have used a single
concentration of several substrates against a single con¬
centration of inhibitor. A difference in "% inhibition"
is purported to suggest selectivity.

However the differing

Km values of the substrate could account for these results.
Consequently,

to effectively suggest selectivity of

reversible inhibitors,

it is necessary to compare Inhibition

of substrates: at concentrations that are equal percentages
of their Km's.

Conclusive evidence for selectivity requires

a full kinetic study determining both the type of inhibition

(4)

and the Kj_ value

(i.e.

concentration of inhibitor at which

enzyme activity is reduced by 50$
Youdim,

),

(Houslay, Tipton &

1976)

In studying the properties of MAO from different organs
and

species,

the assumption is often made that they will

be similar to rat brain and liver in substrate specificity,
differing only in the relatlvepproportion of Type A to B.
A "biphasic" or "double-sigmoidal" curve of $ RAO activity
to a common substrate like TYR versus Inhibitor concentra¬
tion implies substrate oxidation by two enzyme forms.

The

relative proportion of Type A to B is assessed by estimating
the height of the plateau joining the sigmoidal parts of
the curve.
Much recent work base suggested

that the simple binary

classification Of RAO extrapolated from rat studies may
not be universally applicable.

For example,

show a biphasic inhibition of 5”HT,
is a substrate for both types.

suggesting that 5~HT

(Mantle,

Pig brain MAO is reported to be Type B,
toward

5“HT

(Squires,

ox heart studies

et. al.,

1976).

but it is active

1972j Tipton & Spires,

1968).

Lyle

and Callingham haveshown that the apparent biphasic effect
of clorgyllne to BZ oxidation in the rat heart

is due to

contamination by a connective tissue or blood vessel
amine oxidase differing from MAO,(Lyle & Callingham,1975).
This points to a disadvantage in using simple tissue
homogenization for MAO preparation.

(5)

Substrate and

inhibitor specificity can best be studied

in terms of kinetic parameters.

Supersaturating levels

of substrates are frequently used
ties.

in studying MAO proper-

If a so-called Type A substrate is oxidized,

assumed that Type A must be present.

it Is

In fact, Type B has

been found to metabolize Type A substrates and vice versa
(for review,

Fowler,

et,

al.,

1978).

Substrate specificity

is best determined by comparing Km's and reaction velo cities at substrate concentrations at equal percentages
of their Km (Jain,

Sands & Von Korff,

1973).

Ekstedt studied the specificities of Type A and Type B
MAO prepared from intact rat liver mitochondria. Type A
substrates

(5“HT and NE), Type B substrates

2-phenylethylamine,

PEA) and common substrates (TYR and

Tryptaraine, TRYP) were used
In addition,

(BZ and

in mixed-substrate experiments.

the B form was selectively studied by inhibiting

the A form with clorgyllne, and the A form studied by using
deprenyl to inhibit the B form,(Ekstedt,

1976).

Mixed-substrat experiments in uninhibited mitochondria
showed that all six substrates inhibited activity to radiolabelled

5-HT to the same extent.

This Implies that the Km

of each substrate to the A form are equivalent.
inhibited the activity to radiolabeiled PEA,
the same extent.

The substrates

though not to

This suggests differences in the Km of

each substrate to Type B MAO.

(6)

Lineweaver“Burke plots performed on deprenyl-treated
and clorgyline-treated mitochondria revealed competitive
inhibition of all substrates for both A and B MAO,
Deprenyl-treated mitochondria still retained 4# of activity to PEA that could be inhibited by low concentrations
of clorgyllne,

Similarly,

the 2% activity to 5~HT remaining

after clorgyllne treatment was Inhibited by low concen¬
trations of deprenyl.

Thus,

5~HT can be oxidized by Type B

MAO and PEA can be oxidized by Type A MAO.

The Km of 5"HT

for MAO A was 6::x 10"*^ M versus 2.5 x 10™^ for MAO B.
Interestingly,

the Kffl iof PEA for MAO A was also 6,2 x 10

the same as 5-HT,

but PEA's Km for MAO B was 4 x 10 ° M.

Substrate specificity is affected solely by the differing
affinities of the two substrates for MAO B,
It has been found that high concentrations of either
clorgyllne or deprenyl will give 100# inhibition of both
MO A and MO B,

(Neff & Yang,

inhibitor specificity,

1974),

Hence,

substrate and

though significant at physiological

concentrations, will be obscured

by experiments performed

at pharmacological levels,
Jain has criticized

the use of irreversible selective

inhibitors as supporting evidence for multiple enzyme
forms

(Jain,

1977),

Pointing out that pargyline, deprenyl

and clorgyllne all Inhibit MO by stoichiometric binding
to the FAD prosthetic group (Edmondson & Singer,

1976),

»

7

the multiple form hypothesis based on differential inact¬
ivation would require some other molecular basis other
than similarity of binding to the flavin moiety.
Tipton showed that at high clorgyline concentrations,
rat liver MO was inhibited

to 5-HT,

BZ,and TYR,

However,

inhibition of 5~HT oxidation was more rapid than BZ,
oxidation inhibition occurred
to the fast and

in two phases,

TYR

corresponding

slow components for 5-HT and BZ respectively.

Tipton concluded that clorgyline selectivity was caused
by differing rates of attack (Tipton,
Mantle,

1971).

Wilson and Long introduced a new compound,

with clorgyline“like
Wilson & Long,
mitochondria,

inhibitor characteristics

1975a),

PCO,

(Mantle,

In experiments using intact rat liver

PCO inhibition was found to be time-dependent.

After 45 minutes of preincubation,

5-HT inhibition was

100$, with activity toward TYR only reduced 50$, An hundred¬
fold

increase In PCO concentration gave 50$ inhibition ri

without preincubation.

It was concluded

that PCO differential

sensitivity arises from different rates of attack at two
centers of oxidation.

The rate of attack against the

PCO-sensitive site was 200 times faster than the attack
at the insensitive site.

Interestingly,

PCO was a compe¬

titive! inhibitor of TYR oxidation with hyperbolic kinetics.
Hyperbolic competitive kinetics suggests competitive inhi¬
bition at two sites by an inhibitor with different affinities

8
for the two enzyme sites
Still,

(Mantle, V/ilson & Long,

1975b).

these experiments cannot discriminate between one

enzyme with different environments,

two distinct enzymes,

or one enzyme with two sites.
The time-dependent, inhibition by clorgyline was further
investigated by Lyles and Greenawalt.

Many of the experi¬

ments studying the pharmacologically separable forms of MAO
use preincubation periods differing from author to author.
This could alter the characteristics of reported
sensitivity.

enzyme

Using intact rat liver mitochondria the effects

of preincubation time and enzyme concentration were studied
(Lyles & Greenawalt,
For 5-HT,

1977).

time-dependent inhibition was observed only

with clorgyline concentrations equal to 2 x 10

M and

low enzyme amounts. At clorgyline concentrations greater
than 2 x 10

-7

M,

only the second half of the biphasic

curve to TYR oxidation was affected by preincubation.
seemed

that only MAO B was sensitive

It

, an observation

confirmed by preincubation effects at all inhibitor concentrations against BZ oxidation.
The experiments point out that some molecular basis
defining the rate of attack at a catalytic site

» regardless

of the final mechanism of MAO Inactivation at the flavin
moiety, does exist.

Careful attention to pre-incubation

time, assay duration and

protein content must be paid when

C1

comparing data from inhibitor studies of MO,
Lineweaver-Burke plots of substrates in the presence.of
varying concentrations of inhibitor permit classification
of inhibition kinetics.

Changes in the slope,

intercept

or both, reflect competitive, uncompetitive and non¬
competitive
showed

(mixed)

inhibition respectively.

Mantle,

that multiple-substrate experiments with

DA5 TYR, TRYP,
for rat liver

BZ,

PEA all resulted

at,

«1,

5-HT, NE,

in competitive kinetics

(Mantle, Wilson & Lons?, 1975’°).

Substrate competition experiments can be an effective
technique for studying the relationship between differing
enzyme activities.

If two substrates are metabolized at

the same active site,
of each other.

they will be competitive inhibitors

When two active sites are present with

exclusive specificity,

the presence of one substrate

should have no effect on the activity toward

the other.

By setting the concentration of one substrate at its
Km, and

the Inhibiting substrate at twice its K ,

inhibition should be

the

50% if the substrates compete for

the same site, and no inhibition if independent sites are
involved.

If two substrates share the same site,

of a substrate should

equal its Km»

the Kj

Under these conditions,

using adult human brain and liver MO of intact mitochondrla,
White and Wu found

that 5“HT and PEA do not inhibit MAO

activity to each other.

This indicates that these substrates

io

are catalyzed by independent sites.
substrates were not as elearcut

Experiments with other

(White & Wu,

1975).

The interpretation of data derived under the conditions
of these experiments requires certain assumptions that
may not be appropriate.

If either substrate is metabolized

by additional active sites,

the per cent inhibition will

depend

on the affinity and

specific activity of the other

sites.

Another requirement Is that allosteric chancres of

multiple enzyme forms do not occur.
mentally derived K

values used

Finally,

the experi¬

for ad justing substrate

concentrations could be the average of the affinities for
multiple active sites* This has been shown to be true for
rat liver mitochondria
Long,

(Ekstedt,

1976? Mantle,

Wilson &

1975^).

Competitive kinetics can be classified

into linear

and non-linear types by replotting the slopes derived

from

Lineweaver-Burke plots against inhibitor concentration
(Piszklewicz,

1977), The slope of such replots reflects

the effect of an inhibitor at an active site.

Replots that

are linear signify either that there is competition at
only one site,

or that multiple sites are independent and

are kinetically equivalent for substrate and

inhibitor.

Non-linear replots signify competition at multiple sites
or allosteric effects on a single site.

They are designated

either hyperbolic, with a convex-upward curve,
with a concave-upward curve.

or parabolic,

/ /

By extrapolating the initial and

final slopes of non¬

linear replots to the inhibitor concentration axis

(abscissa),

two apparent K.’ s reflecting high and low modes of inhibitor
binding are obtained,

Hyperbolic plots show high affinity

binding at low Inhibitor concentrations, while parabolic
plots show high affinity binding at high inhibitor concen¬
trations.

(Fig,

2)

Computer simulation of the competitive inhibition of
two independent active sites kinetlcally similar for the
substrate but with two differing affinities for the inhib¬
itor yields hyperbolic kinetics
1975^)*
model,

(Mantle,

Wilson & Long,

Parabolic replots cannot be derived

t

from such a

and are evidence for an Interacting site model of

enzyme activity.
In all mixed-substrate experiments that show competi¬
tive inhibition,
of the labelled

the inhibition Is in effect a dilution
product of the substrate by the unlabelled

products of the competitive inhibitor.
by double-label experiments.
equivalent to the

This can be shown

Consequently,

the

is

of the inhibitor at an active site.

The fit between experimentally derived Km*s and K^'s for
substrates and

their correlation to computer derived

kinetic parameters will differentiate between hyperbolic
kinetics from two independent sites or two interacting
sites.

II

Mantle,

Wilson and Long found linear kinetics for all

substrates versus 5~HT oxidation suggesting one site of
MO activity for 5“HT.

Linear replots we re obtained

most substrate interactions.

However,

inhibit the "common substrates"
kinetics.

u

5~HT was found to

DA and TYR by hyperbolic

The good correlations between K

experimentally, and to simulated

for

's and K^*s

plots point to the

existence of two independent active sites for MO oxida¬
tion

(Mantle,

Wilson & Long,

1975"b).

This is in agreement

with work on rat liver showing two Km9s for 5-HT differing
by two orders of magnitude

(Ekstedt,

1976).

T3
3

Fig. 2.

Computer simulation of hyperbolic slope replot

for competitive inhibition of 2 klnetically equivalent
sites for substrate by an inhibitor with different
affinities

(K^ = high affinity; K^= low affinity)

two Independent sites.
tions.

(Mantle,

Dotted

for

lines represent extrapola¬

Wilson and Long,

1975^)

II
MULTIPLE FORMS-ELECTROPHORESIS

The heterogeneity of MO activity revealed by pharmaco¬
logical studies prompted

the

implementation of elec¬

trophoretic techniques for elucidating the structural
basis of this behavior.
In 1967, Youdim and

Sandler used

polyacrylamide gel

electrophoresis to separate different constituents of
solubilized MAO from rat liver and human placenta
& Sandler,

1967),

(Youdim

Soon after, Kira and D’lorio used cellulose

acetate electrophoresis to describe multiple bands of MO
activity from rat liver homogenates.

In addition,

they

reported similar results when solubilization by detergent
was compared

to sonlcation

(Kim & D’lorio,

1968).

Kim and

D’lorio were not willing to preclude either incomplete
solubilization or enzyme association with subparticles of
membrane debris as explanations for the multiple bands.
Youdim followed his initial work with experiments to
characterize the properties of the electrophoretic bands.
Briefly summarized,
were similar*

it was found

yet the V

max

that K

's were not.

*s for substrates
The bands showed

differing inhibitor sensitivities, differing pH optima
for maximal kynuramine

(KYN)

oxidation, and differing

susceptibility to heat inactivation:(Youdim, Collins &
Sandler,

1970).

The results were similar for both rat liver

and brain (Collins,

Sandler,

The molecular weights

(MW)

Williams & Youdim,

1970).

of the bands were equivalent,

14

-

290,000-320,000,
gation,

by gel filtration.

the bands had a MW= 150,000

With ultracentrifu¬
(Youdlm &_ Collins,

1971).

The denaturation of partially purified rat liver MO
with 8M urea or 1% sodium dodecyl sulfate

(SDS)

a single band upon electrophoresis. The band had

yielded
100% loss

of activity, and a molecular weight of 78,000. Reassociation
by dialysis resulted

in 5 bands on electrophoresis,

similar

to the non-denatured preparation. When each Isolated band
of activity was subjected
of MW- 76,000 migrated

to denaturation, a single band

identical to the band of denatured

whole enzyme preparation.
and electrophoresis,

However, upon reassociation

each original band of activity resulted

in 5 bands with a pattern identical to the denaturedreassociated whole enzyme preparation (Youdlm & Collins,
1971).
Youdlm and Collins interpreted

their results as revealing

an MAO consisting of inactive subunits of MW = ?8,000.‘
they concluded that MAO could not be an enzyme of MW ~ 150,000
with two sub-units, nor an enzyme with four sub-units and
a MV/ = 300,000.

They only entertained

two dissimilar sub-units,
site

the possibility of

one with a substrate binding

(Ss), and one without

(S).

Thus, an enzyme with two

sub-units would permit only two active forms

(SsS and 2Ss),

and an enzyme with four sub-units would give only four
active forms

(4Ss,

3SsS,

2Ss2S,

Ss3S).

Neither model gives

15

the five active forms achieved by electrophoresis.

Instead

the authors felt the five active forms could represent
conformational enzymes,
ture.

differing only in tertiary struc¬

This would also also explain how the denaturatlon-

reassoeiation of each individual form could yield all five
forms

(Youdim Sc Collins,

the authors assumed

1971).

It should be noted that

that the five forms are not artefacts

of their solubilization procedure.

Nor did

they entertain

other models of sub-unit interaction in an enzyme.
example,

For

two inactive sub-units of MW ™ 75»000 may be

necessary to bind with the FAD cofacter to yield an active
enzyme with MW ~ 150,000.
Sierens and D'lorlo pointed out the problems inherent
in the harsh solubilization techniques.

Using the ionic

detergent deoxycholate and gel electrophoresis,

they were

able to separate two fractions of MO activity from rat
liver mitochondria

(Sierens & D’lorio,

acted on BZ and 5“HT,
compared

the other on BZ alone.

to untreated mitochondria,

reduced activity.

1970),

One fraction
However,

both fractions had

MAO activity to 5“HT was only 2% and

BZ but 20^ in the first fraction.

to

Further experimentation

showed that dialysis partially prevented the loss of acti¬
vity, Deoxycholate bound to enzyme could not explain the
results as it did not migrate with either fraction.
The authors concluded

that the apparant MO multiplicity

was likely secondary to Irreversible damage to 5~HT activity,
and not to KAO Isoenzymes differing in protein constitution.
This experiment pointed out both the need

for a solubili¬

zation method that causes only a minor reduction in activity
as tested against several substrates, and that chromato¬
graphic or electrophoretic

separations alone are not

sufficient for establishing enzyme multiplicity.
In later work,

Diaz,

Sierens and D’lorio were able to

partially separate 5~HT activity from BZ activity using
density grad lent electrophoresis and

sonication with only

a 20-25/e reduction of MAO activity to BZ,

5‘a,HT and KYN.

The results were suggestive of at least two different
activities,
two enzymes,

though the data could not distinguish between
multiple forms of one enzyme,

or association

of enzyme with non-protein molecules (Diaz-Borges & D’Xorio,
1972)
Oreland and Olivecrona studied
mitochondria and

found

the binding of KAO to

that the liberation of soluble MAO

enzyme correlated with the extraction of cardlolipin, an
anionic phospholipid.
found

Using purified

phospholipids,

soluble complexes of MAO and cardiollpin,

complexes if the cardiollpin were bound
mitochondrial membrane residues
Olivecrona & Oreland,

1971). '

they

or insoluble

to delipldated

(Oreland & Olivecrona,

1971j

n

Tipton explored

the relationship between separate

activities of MAO and bound membrane material by measuring
the phospholipid
forms of MAO

content of electrophoretically separable

(Tipton*

1972),

Phospholipid content and

mobility were Inversely related, with the fastest moving
band having the lowest amount of phospholipid,

Reasoning,

that if lipids were responsible for apparant isoenzymes,
then the distribution of electrophoretic forms should be
affected by techniques that extract lipids.
caused a significant loss of activity,

Organic solvents

but the non“ionic

detergent Triton X-100 yielded only a single band with
mobility similar to the fastest moving band.
Tipton stated
activity to BZ,
MAO.

that Triton X-100 had no effect on MAO
5~H?»

DA or TYR, using purified rat liver

He did not report his results, and

it is difficult

to rule out the possibility of damage to one enzyme form
that could be obscured by measuring activity against
non-separated
Tipton did

preparation.
find

that prolonged dialysis against Triton

X-100 or Phospholipase A resulted
vity,

in the loss of MAO acti¬

though a single band was still observed.

the possibility that lipid
MAO, and

a

This raised

is vital to the stability of

that the loss of electrophoretic heterogeneity

could result from the denaturation of active forms.
Oreland

showed

that

1.5% Triton X-100 for three hours

did not affect the K

of BZ,

compared to a mitochondrial

Xu

preparation (l.e.

enzyme in situ)

the Vmax was reduced

,

of pig liver M0»

but

in agreement with Tipton.

To circumvent the methodological issue raised by
detergent' binding'to enzyme, Oreland used an organic
solvent and

salt solubilization-purificatIon procedure

with a yield of
were lowered

20% MO activity. Both the K

for BZ,

played by lipids

and V

corroborating the influential role

(Oreland,

1972).

Oreland did not feel that his extraction procedure may
have preferentially lost one of the isoenzymes,

though

it could account for the change in Michaelis parameters
versus the enzyme in situ.

For example,

the loss of a form

with a higher Km for BZ that signifIcantly contributes to
BZ oxidation at the BZ concentration used,

could appear

as a decrease of Km and Vmax.
Oreland concluded this was not the case because the
percentage activities to various substrates versus activity
to TYR were not signifIcantly changed.

Such experiments are

carried out at a single substrate concentration signifi¬
cantly higher than its
The activity recorded
Consequently,

to ensure enzyme saturation.
is then considered

the V

.

the loss of one form would be observed only

if it were responsible for a significant portion of enzyme
activity at that substrate concentration.

Pharmacological experiments with pig liver found
only the B form,

so Oreland's work is not conclusive

(Squires,

In later experiments with rat liver,

1972).

Oreland discovered the preferential loss of Type A
activity with retention of the B form (Ekstedt & Oreland,
1975).
Houslay and Tipton continued

the Investigation of

i. >3

protein-membrane interactions and rat liver MAO by using
sodium perchlorate, a chaotropic agent.

These compounds

are capable of weakening hydrophobic bonds between proteins
and lipids,

thus disrupting protein-membrane complexes.

Polyacrylamide gel electrophoresis x-zas used

to compare

a perchlorate-treated

solubilized enzyme preparation, an

untreated

enzyme preparation, and a mitochon¬

solubilized

drial outer membrane preparation that contained 90)? of
enzyme activity.

Both the outer membrane preparation

representing KAO in situ, and

the perchlorate-treated•

enzyme showed one band of activity migrating similar to
the slowest moving band of the untreated enzyme.
addition,

In

one band of activity originally described by

Youdim was found

to be an artifact of the gel loading

procedure,
Sodium perchlorate treatment caused no loss of activity
for incubation periods up to ten minutes.

There was no

difference in the Km or Vmax for BZ, TYR or DA,

suggesting
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that perchlorate treatment did not alter the active site
of the enzyme.
inactivation,

All substrate“related differences in heat
pH optima, and

inhibitor effects of harmine,

phenylethylhydrazine and clorgyline were abolished
perchlorate treatment

(Houslay & Tipton,

by

1973).

Houslay and Tipton concluded that the apparant electro¬
phoretic heterogeneity and

substrate specific activities

of MAO were probably secondary to the solubilization proce¬
dure.

The electrophoretic heterogeneity did not exist In

the mitochondrial outer membrane preparation,

though none

of the other parameters of heterogeneity were tested.
speculated

They

that the vigorous sonlcation-detergent steps

could result in unknown complexes of membrane lipid,

enzyme

and Triton X-100 causing apparant multiple forms.
It is not possible to categorically deny the existence
of multiple forms since the solubilized

enzyme preparation

retained less than 50% of the original activity.
context,

it should be recognized that Houslay and Tipton

used 2% Triton X-100,
(Tipton,

In this

previously found

1972; Oreland,

1972), and

to inactivate MAO

50 mM Trls buffer, a

reversible non-competitive inhibitor of TYR,
PEA oxidation with a
& Houslay,

1977).

5“HT and

of 15 "25 mM (Fowler, Callingham

BZ Is not inhibited by Tris,

Consequently,

all experiments exploring substrate-spec ificity are most
difficult to interpret.
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Singer has warned that all chaotropic agents affect
protein structure.
may be intact,

While catalytic and

the more subtle and

significant in vivo

regulatory properties can be modified
Jain and Sands reviewed
retic heterogeneity and

inhibitory prropertles

(Singer,

1976).

the literature on electropho¬

found

that all such reports used

extended periods of sonication for their enzyme preparations.
By using a non-sonication procedure for solubilization of
human brain MAO,

they found only a single band of activity

on polyacrylamide gel electrophoresis.
Mlchaelis constants for this purified

In addition,

the

enzyme were very

similar to those of an intact mitochondrial enzyme prepa¬
ration.

Thus Jain and

Sands added evidence to the artefact

theory of MAO electrophoretic multiplicity,
sonication (Jain and

Sands,

implicating

197^).

The non-sonication procedure used by Jain and

Sands was

originally developed by McCauley and Racker.

This purifi¬

cation used lOOmM Tris and

(McCauley &

Racker,

1973).

1.5% Triton X-100

The Mlchaelis constants were derived from

a solution of 100 mM potassium phosphate buffer, a
significant inhibitor of MAO
Van Woert & Cotzias,

1966).

similar to those reported
MAO

(White & Glassman,

(Jain,

Sands & Von Korff,

19735

These constants were very

for the B form of human brain

1977).

Sonication does not invariably lead to electrophoretic

2Z

heterogeneity, as studies on the human platelet have
revealed
contended

(Collins & Sandler,

1971).

Sandler and Youdim

that sonicationwould have been expected

to

give

an infinite gradation of membrane particles rather than
the reproducible bands

(Sandler & Youdim,

1972).

It has

been pointed out that specific sites in the protein structure
may exist at which it will preferentially split or dissoci¬
ate under the stress of sonicatlon or solubilization
(Jain,

1977).

All of the work referred to above on multiple bands of
MAO activity used a colourimetric technique for localizing
MAO activity with nitroblue tetrazollum reduction by MAO
as the marker.

However,

some MAO substrates themselves

can reduce tetrazollum (NTZ)

salts

(Lagnado & Sourkes,1958),

and NTZ strongly inhibits MAO activity as compared to
radioassay techniques

(Lagnado,

Okamoto & Youdim,

1971).

It is also possible that one of the enzyme forms is not
MAO,

though It can oxidize monoamines to give electrons

to NTZ yielding a positive reaction (Guha & Ghosh,

1970).

The existence of such an enzyme with activity toward
TRYP and

inhibited

brain of rats

by iproniazid has been detected

(Ghosh & Guha,

1978).

Diaz-Borges and D’lorlo used
12.5# Lubrol and

the non-ionic detergent

sonicatlon to prepare rat liver MAO and

0.4# Lubrol in solutions for polyacrylamide gel

a ’

in the

•

electrophoresis
radioassay,

(Diaz-Borges & D'lorio,

1973).

Using a

they achieved a complete separation of BZ

and 5-HT activity with overlapping activity toward TYR.
Upon comparing the radioassay to NTZ staining,
correlation was seen.
mixture gave a broad

little

5-HT, TYR or TRYP in the staining
purple band

that was abolished by

pre-incubation with the MAO inhibitor isocarboxid.
band was observed with BZ as the substrate.

No such

Staining of

the gels with BZ, TYR or TRYP gave a yellowish-purple
backround with soma zones lighter or darker,
appearance of bands.

However,

failed to abolish this effect,

giving the

isocarboxid pretreatment

•

suggesting it was not due

to MAO activity.
These experiments point out the inadequacies of colourimetric

staining for detection of MO activity.

They'are

remarkable for the total independence of electrophoretic
mobility of 3Z and

5-HT activity, analogous to Johnston's

mod el.
The solubilization technique used had previously been
shown to give 83$ recovery of BZ activity and
of 5-HT activity,

so the possibility of selective degra¬

dation of one form is less likely
1972).

79$ recovery

(Diaz-Borges & D'lorio,

Experiments on the separate activities assessing

phospholipid content,

MW, activity after chaotropic

treatment, and pharmacologic,

immunologic and kinetic

2.4-

characterlstics are necessary to establish the existence
of two distinct enzyme proteins,
Inoue,

Robinson and Dost compared radioassay and colour!-

metric assays using rat liver and brain prepared according
to Youdlra in 1.5% Triton X~100.

Additionally,

the prepara¬

tion was dialyzed against phosphate buffer for over 60 hours
to remove the Triton X-100

(Inoue, Robinson & Dost,

1976),

Where four bands were found on gel electrophoresis with
NTZ,

only one band

with NTZ)

(corresponding to the least mobile one
1

had activity with a C"

h

“-labelled

substrate. The

results were the same using radiolabelled BZ, TRY? or TYR.
Consequently,

the Triton X-100 per se does not cause the

heterogeneity observed by Youdira,

though all work using

NTZ must still be viewed with caution.

MOLECULAR WEIGHT OF MAO

The molecular weight of MAO has been studied to
elucidate the nature of the multiple activities.
general,

In

the MV/ has been measured by various investigators

with little agreement.

Only If the molecular weight is

calculated per mole of flavin,

the enzyme co-factor,

is

there agreement - 1,2 - 1.5 x 10^ g mao per mole of
Qc< ~

(cysteinyl)FAD

(Sandler & Youdim,

1972),

Youdim and Collins, using a 1,5$ Triton X-100 prepa¬
ration of rat liver MAO found a MW = 300,000 for both
whole enzyme and

Its electrophoretically separated

using Sephadex gel filtration.
tion gave a MW = 150,000.

forms

However, ultracentrifuga¬

8 M urea or 1% SDS yielded

inactive sub-units with MW = 75,000 by gel filtration.
By using phenelzine, an irreversible MAO inhibitor that
binds to the flavin moiety,

Youdim found a molar ratio of

Phenelzine / FAD / 150,000 MW

(Youdim & Collins,

Orelandf using a ketone extraction method,

1971).

obtained a

purified MAO with a strong tendency to aggregate. A series
of gel filtrations on Sephadex G-200 with increasing
concentrations of the ionic detergent sodium cholate,

gave

a MW - 290,000 for enzyme still active to BZ in 2.5$
cholate.

10$ cholate showed two peaks of activity,

at 290,000 and another at 115,000.

When the enzyme of

MW - 115,000 was rechromotographed without cholate,
aggregated and appeared

one

in the void volume.

It

Using pargyline,

Oreland

found a molar ratio of 1

flavin/ protein of MW ” 115»000
Interpreted

;

1

:

1

(Oreland,

of pargylino/
1972).

Oreland

these results to suggest protein aggregation

as the basis for electrophoretic heterogeneity. An
alternative interpretation is that the sodium cholate
may have affected the retention on the column,

giving

falsely decreased estimations of MW.
Shih and Eiduson solubilized rat brain MAO in Triton
X-100 and used both agarose and

Sephadex electrophoresis

to separate MAO. Agarose separation yielded two fractions,
A s.nd B (not to be confused with Johnston’s pharmacological

6

designations) with MW=1.5-10 d

and 500,000 respectively.

To investigate the question of aggregation,
reehromotographed

the MAO was

in the presence of 8M urea,

speculating

that A would disappear, with a concomitant Increase in B.
In fact,

soma of A did disappear,

but all of B seemed to

disaggregate to a fraction C with a smaller MV/.
fractions were active to 5~HT,
tography of B alone showed

BZ, TRYJ? and PEA.

All
Rechroma¬

partial reaggregation to A.

Further, when low concentrations of enzyme preparation
were added to the agarose column,
converted

to C,

some of A and all of B

Sephadex G-200 chromatography yielded

analogous results.
In general the specific activity to substrates increased
with separation,

i.e.

C>B)A,

though the change was not
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consistent through the steps.

This differential increase

in specific activity was interpreted as evidence for forms
of MAO that differ in teh aggregation of sub-units
& Eiduson,

(Shih

1974).

Experiments by Inoue,
explanation,

Robinson and Dost suggest another

Noting the wide use of Triton X-100 in

solubilization procedures,

they pointed

out that dialysis

to remove the detergent from the partially purified enzyme
is rarely carried out

(Xnoue,

Robinson & Dost,

1976).

If dialysis were for less than 60 hours for rat liver
and brain MAO, a significant amount of MAO activity was
held up on Sephadex G-200,
volume,

Most came off in the void

in agreement with Oreland and

The portion held up corresponded

Shih and Eidus on.

to Fraction B.

Dialysis

for longer than 60 hours showed a single peak of activity
appearing in the void volume,
Inoue felt this phenomenon could be due to the high
affinity of the protein to the Triton X-100 with stabili¬
zation of the enzyme in a disaggregated

form. As little as

0.3$ Triton X-100 added to enzyme dialyzed
and already passed through the column,

for 60 hours

caused the complete

retardation of enzyme activity on Sephadex G-200.
variable gel filtration behavior used

Consequently,

to show multiple

forms and to determine the MW can be partially attributed
to differing amounts of detergent remaining in the enzyme.

IMMUN0LOGICAL APPR0ACHES

The controversy over multiple forms led some investi¬
gators to employ immunological techniques in the investi¬
gation of enzyme heterogeneity.

In general,

the degree of

structural-relatedness of MAO forms was studied using
antigen-antibody cross-reactivity in double diffusion
experiments.
Hartmann and Udenfrlend used bovine liver separated
three fractions with MAO activity

int

(Hartmann & Udenfrlend,

1972).Two of the forms were pure protein, designated
C^ with MU-400,000 and 4 moles FAD per mole, and C^ with
MW=1,200,000 and

12 moles FAD per mole.

The third

form

was a protein fraction contaminated by other proteins
and residual Triton X-100,

designated

Fraction A.

Antibodies were induced against C2 because it would
presumably contain the most antigenic sites with some
differing from C^ and Fraction A.

Immunodiffusion yielded

single precipitin lines without spurs,

suggesting both

antigenic identity and the absence of sites on C2 not
found on the other forms.

The impurity of Fraction A

left the possibility of an MAO antigenically distinct from
C

.

Immunoprecipitin titration resulted

in the total

removal of MAO activity from Fraction A, ruling out the
presence of a structurally unrelated form.
C2 antibody tested against a crude Triton X-100 solubi¬
lized liver MAO gave

93$ removal of MAO activity.

preparation retained only
to BZ,

65$

The

of total liver MAO activity

so the possibility of a denatured form exists.

Cross-reacting C£ antibody to bovine brain MO left
immunoprecipitin lines of identity without spurs.
immunotitration could

Yet,

precipitate only 80/6 of brain MO

activity to BZ'. The remaining 20% was felt to represent
a "brain-specific MO" antigenically distinct.
It would

be Interesting to explore these immunologlcally

separable forms with other substrates and
proper kinetic techniques, and

inhibitors using

to see if antibody to the

"brain-specific MAO" could be induced.
McCauley and Racker extended the work on bovine brain
and liver MAG antigenicity,
differred
1973).

though their antigen preparation

from Eartmann and Udenfriend

They added

(McCauley & Racker,

the use of selective Inhibitors and

more substrates to characterize brain MAO activity not
preclpltable by antibody Indue cc'i* gainst liver MAO.
Essentially,

they found that non-precipltable MO had

activity to 5~HT and
BZ.

NE much greater than its activity to

Precipitable MO had no activity to 5“HT or NE, while

retaining significant activity to BZ.

Both forms had activity

to DA and TYR. The non-precipitable activity toward NE and
5-HT was inhibited by harmaline, an MO A inhibitor, and
resistant to pargyline inhibition.

The precipitated MAO

showed the reverse inhibitor sensitivity.
These results are analogous to Johnston's model,

so

McCauley and Racker concluded that non-precipitable brain

BO

MO was indeed Type A MO, a form antigenieally distinct
from bovine liver MAO,
Unfortunately,

designated Type B,

the authors did not attempt iramunotltra-

tion or the addition of anti-globulin to the supernatant
to rule out incomplete precipitation secondary to soluble
antigen-antibody complexes.

Therefore

»

it is still con¬

ceivable that the two pharmacologic types differ only in
the number of similar sub-units.
Dennick and Mayer prepared rat and human liver MAO
specifically purified by prolonged t»5% Triton X-100
incubation to electrophoretic homogeneity in the presence
of SDS, Activity to 5™HT was completely lost, and only._

3% of total activity was retained,(Dennick & Mayer, 1977).
Antibody induced

from this MAO preparation was able to

immunoprecipitate 100% of. the activity to 5~HT,
TYR in liver mitochondrial extracts by
of anti-serum,

BZ and

equal n. volumes

Dennick and Mayer concluded that all liver

MAO activity resides in one macromolecular species.
This conclusion is legitimate only if the specificity
for a substrate is absolute.

The relative activities of

the liver mitochondrial extracts suggest that MO A, with
its activity toward
was not present.

5-HT greater than its activity to BZ,

Inhibitor studies of the mitochondrial

extracts might have proven Illuminating. The extended
Triton X-10Q treatment used

in their preparation could
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have preferentially denatured an A type MAO more dependent
on lipid moieties for activity.
Youdim has shown that SDS will yield a homogeneous protein
from active multiple forms,

that is inactive with a MW .one-

half to one-quarter that of active MO. Consequently,
Dennick and Mayer may have formed antibody to an inactivated
I4.A0 A,

though not antigenically destroyed.

All the immunologic studies are equally consistent with
a single enzyme modified by membrane-binding masking the
antigenic response
than one enzyme.

(Toozg,

1973)j

or the presence of more

ONTOGENIC PATTERNS

The ontogenesis of MAO has been studied
of many species
the rat brain,

(for review,

Gripols,

in many organs

1975).

Eiduson

liver and heart using polyacrylamide gel

electrophoresis and NTZ staining.

He found differences

between adult and neonatal rats in the number and position
of bands, and that testosterone could affect the number
of bands

( Eiduson,

1972),

Blatchford, Holzbauer and

Youdim found that the specific activity to TYR and DA
increased with age in the hypothalamus and
three rat strains.
thalamus and

TRYP oxidation decreased

striatum of
in the hypo¬

striatum from only two of the strains,

suggesting age,

species and

substrate effects on the

development of MAO activity (Blatchford,

Holzbauer & Youdim,

1975).
Jourdikian attempted

to classify maturational rates

of Type A versus Type B MO in the mouse brain.

Type A,

identified by using 5~*HT as a substrate and clorgyline as
an inhibitor,

reached adult levels by 20 days old, when

Type B was only 50% adult values
Alivisatos,

(Jourdikian, Tabakoff &

1975).

In the rat,
system of MAO.

fetal liver has a fully developed binary
However,

fetal brain MAO was 97% Type A.

It is not until Day 45 post-natally that the adult propor¬
tions of 60$ A

:

Tipton,

Mantle speculated that Type A may represent

1976).

30$ B is achieved

(Mantle,

Garrett &

a fetal form since it is the predominant type in glioma
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and neuroblastoma

(Donnelly,

Richelson & Murphy,

Using a different strain of rats,

1976).

Bourgoin discovered

adult levels of MO B by Day 20, while MAO A activity was
80% higher in brain stem homogenates and 20$ higher in
forebraln homogenates at Day 20 post~natally, as compared
to adult rats.

Kinetic analysis revealed a higher V_Q„

in neonatal rats with no difference in the K

of 5“HT,

implying greater amounts of enzyme in the pup. At birth,
rat brain 5-Hydroxyindole acetic acid
to adult 5-HIAA,
adult levels
1977).

(5raHJAA)

though 5“HT at birth is only

(Bourgoin,

et.al,,

197^*

is equal

33% of

Bourgoin,

et.

al,,

Thus maturational changes In MAO activity are

significant for the regulation of brain monoamines.
Experiments in the ontogenesis of MAO have not discrimi¬
nated between changes with age of brain lipids,
or protein molecules.

mitochondria

They do bring evidence pointing to

the Importance of the distinction between MAO activities,
each under different regulation.
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MAO IN SITU - THE MITOCHONDRION

The work of Schnaltman and Greenawalt has localized
KAO to the outer membrane of the mitochondrion.
outer membrane

(OH)

can be dissociated

matrix (M) and

inner mitochondrial membrane

dlgltonin treatment.

The

from both the
(IM) by

The small vesicles formed

from OK

were found to have a greatly increased specific activity
for MAO and represented a large fraction of the total
mitochondrial MAO activity.

The IM-M fraction, called

mltoplasts, retain essentially no MAO activity (Greenawalt,
1972).
Mitochondrial membranes are dynamic structures with
their components undergoing continuous turnover. The
IM and OM proteins undergo independent, asynchronous
synthesis

(C-ear,

in the IM,
and

1970).

2.0% of mitochondrial protein is

10% in the matrix,

6% as intermembrane protein,

only

in the OM (Schnaltman & Greenawalt,

1968).

as a result,

changes in the ratio of IM to OM,

or OM to

mitochondrion could cause changes in the amount of enzyme
activity per amount of protein.
heart is 20

%

The IM

1, while in- liver it is 5

s OM ratio in rat
*

1.

This could

explain the relatively lower MAO activity of heart mito¬
chondria

(Greenawalt,

to protein ratios and

1972).

in the lipid composition of the two

membranes have been reported

i

Differences in phospholipid

(Ernster & Kuylenstierna,

1970).
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Thls intimate localization of MAO in the OM forms the
basis for much of the dispute regarding enzyme multiplicity.
Membrane“bound enzymes have a tendency to change charac¬
teristics upon solubilization and purification.
changes are referred to as allotopic properties,

These
Houslay

and Tipton found that solubilization of MAO causes a
significant alteration in the kinetic mechanism.

It

implies the necessity for the enzyme to adopt a conformation
normally dictated by the membrane environment
Tipton,

1975)*

(Houslay &

Perchlorate treatment abolished the Diphasic

inhibition pattern of both deprenyl

(Tipton, Houslay & Mr

Mantle,

1976) and clorgyline to TYR oxidation (

Tipton,

1973).

The mitochondrial environment could
conformations on one protein,
one of several proteins,

Houslay &

enforce specific

preferentially stabilize

or expose different catalytic

sites on one protein. Any of these alternatives would
present multiple enzyme activities in vivo.

The allotopic properties of-MAO suggest that the
microenvironment plays a significant role in MAO activity,
especially in creating a relatively non-polar environment
to favor amine oxidation.
MAO in purified

Some investigators have studle

intact mitochondria in an attempt to resolve

inconsistencies and

to elucidate the action of the enzyme

in a more natural state,
Gahay used a mitochondrial preparation from bovine brain
with a fair degree of morphological integrity and freedom
from contamination as assessed by electron microscopy and
enzyme marker studies. This preparation had 80$ of the MAO
activity found

in brain homogenates

(Gabay, Achee & Mentes,

1976).
Substrates were tested against pH,

ions and

thermostability,

all expected to affect environmental conditions.
species seemed

to have no effect,

Cationic

but phenylalkylamines

(PEA, TYR)were more affected by phosphate ions, and the
lndolealkylamines
chloride ions.

'were more susceptible to inhibition by

Increased chloride gave non-competitive . .?.

inhibition to the lndolealkylamines and mixed-competitive
inhibition to the phenylalkylamines. This might indicate
a difference in binding groups for the substrates within
an active site,
Gabay also reported differing pH optima for the Km and
V

max

of the substrates.

There have been studies implying
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that the true substrate for MAO is the unprotonated amine
(McEwen,
1974),

et. al,,

1968;

McEwen,

et, al,,

19^9* Williams,

Upon correcting for the degree of ionization,

Gabay found that the the optimal pH for the Michaelis
cdnstants of the unionized amines was pH= 7,4,

Finally,

there was no difference in thermostability to any substrate
in intact mitochondria,

though this has been reported

as evidence for the existence of multiple forms,
Clorgyline and harmaline were found
for 5-HT activity versus PEA,

to be selective

but dose-response curves

were biphasic for all substrates. The Type B inhibitor
deprenyl required pre-incubation to give substrate selecti¬
vity at low inhibitor concentrations.
stemmed

The difference

from the slower rate of PEA inactivation.

This

was true for high clorgyline concentrations also.
Mixed-inhibitor studies were most suggestive of two
sites distinct for different inhibitors though not
mutually exclusive for substrates. The combination of
Type A and Type B inhibitor had additive effects to achieve
total MAO inhibition, whereas two inhibitors of the same
type gave only partial inactivation.(Achee & Gabay,

1977),

Of Interest was the finding that 100$ inhibition of
5-HT was never achieved by these authors,

though activity

to all other substrates could be totally abolished,
Williams found 5-HT oxidizing activity localized

in the
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circumventricular structures of rat brain that is not
inhibited by high elorgyline concentrations
Gascoigne & Williams,

1975).

studies have yet to be done,

(Williams,

Though substrate and

inhibitor

these results are clinically

significant for the suggestion of an MO type Intimately
associated with the hypothalamus and C3F distinct from ' •
the activities normally studied.
Improvement in subeellular fractionation using density
and zonal centrifugation have led to the conclusion that
mitochondrial populations are heterogenous.

Differences in

bouyant density and enzyme activity have been reported.
brain,

In

it has been possible to separate neuronal and glial

mitochondria, and
mitochondria

synaptosomal and non-synaptosomal

(for review,

Van den Berg,1973).

The first report of mitochondrial heterogeneity of MO
activity was by Kroon and Veldstra, using homogenization
of rat brain In isotonic sucrose to separate out synap¬
tosomal mitochondria.

Zonal centrifugation in sucrose

density gradient gave a partial separation of synaptosomes
and free mitochondria.
suggested

The distribution of enzyme activities

that MAO activity to 5”HT and DA is localized

in

mitochondria differing from NE and KYN oxidizing MO,
(Kroon & Veldstra,

1972).

High sucrose densities cause marked mitochondrial and
synaptosomal distortion through osmotic shifts,

so Youdim

3<3

used an iso-osmotic Ficoll-sucrose gradient to prevent
artefacts

(Youdim,

197^).

Rat brain and

liver showed

heterogeneity of MO activity to TYR, TRYP,

KYN and DA,

though no fraction had activity exclusive for any substrate.
The MO activity as measured by Youdim and Kroon and
Veldstra were using substrates at saturating concentratins.
All of Youdim*s substrates are "common'’ as defined by
Johnston pharmacologically.

The heterogeneity could represent

differences in the proportion of MAO A to MO B in the
mitochondria.

In this vein,

Neff used

sucrose density

gradients and

found two regions of activity to TYR, Using

5-HT-MO

the ratio of PEA-MO activity to

activity,

it

was found that mitochondria with higher bouyant density
seemed to have MO B by virtue of its high PEA:5~HT
oxidizing ratio

(Neff, Yang & Puentes,

197*0.

Owen used a Ficoll-sucrose discontinuous gradient to
separate three populations of rat brain mitochondria.
Two were derived from synaptosomes, and a third ostensibly
non-synaptosomal and glial

(Owen,

synaptosomal populations had
5-HT,

et. al.,

The

equal specific activity to

but all three groups differed

to PEA,

1977).

in specific activity

The heavy synaptosomal fraction (SM2) had greater

PEA-MAO activity than the light
mitochondrial

population had

to both substrates.

(SMI)

population.

The free

the lowest specific activity

4o

Clorgyline and deprenyl gave biphaslc inhibition of
TYR oxidation in all fractions.

The plateaus suggested that

SMI had a greater proportion of MAO A than did SM2,

SMI,

with the lowest PEA55“HT activity ratio was most susceptible
to clorgyline and least sensitive to deprenyl.

The reverse

was true for the SM2 fraction.
These findings were extended to mouse lung mitochondria
separated Into a light population with low PEA; 5~HT activity
ratio and a denser population with high PEAs5-HT activity
ratio

(Gallagher,

with pargyline

1977).

When the mouse was pretreated

(MAO B inhibitor)

before sacrifice,

MO activity remained high and peaked

5“HT

in the light mito¬

chondrial fraction, while PEA oxidation was almost completely
blocked.

Pretreatment with clorgyline strongly inhibited

5-HT oxidation, while activity to PEA was unaffected, and
peaked at the high density fraction.
The use of lung mitochondria avoid contamination with
membranous material found

in synaptosomal preparations.

These results confirm the separation of substrate-specif1c
MAO activity In heterogenous mitochondrial populations.
It is interesting that brain and lung seem to have MO B
in a denser mitochondrial population.

One could

speculate

that differing lipid 1 protein ratios may be involved.
Student and Edwards added

sub-synaptosomal fractionation

to the studies of rat brain and found no selective
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localization of either type MAO on the synaptic plasma
membrane

(Student & Edwards,

1977).

Consequently,

the

difference in Type A to Type B MAO proportions seem to be
inherent in the mitochondria themselves.

Synaptosomal

mitochondria seem to have more MAO A and less MAO B
relative to non~synaptosomal mitochondria.
Upon comparing the specific activity of synaptosomal
MAO to whole brain homogenates,

the ratio of MAO B to

MAO A in the synaptosomes was 43$ that of the homogenater
ratio,

reflecting a doubling of synaptosomal MAO A specific

activity.

Free mitochondria and homogenate had the same

ratio,
The ratio of MAO B to MAO A in synaptosomes from cerehelium was 400$ the ratio in cortex.
regions gave only a 30$ difference.

Homogenates of these
These results demonstrate

that the use of brain homogenates to assess MO activity
can obscure differences in activity at the significant
cellular location - the synapse.

LIPIDS AND MAO HETEROGENEITY

After Tipton demonstrated
was inversely related
1972), and

that electrophoretic mobility

to phospholipid content

(Tipton,

that chaotropic treatment caused a loss of

electrophoretic heterogeneity

(Houslay & Tipton,

1973)»

it became important to explore the role of lipids in the
binary system of MAO generated

from pharmacological data.

The blphasic inhibition by Clorgyline and Deprenyl of
rat liver MO activity to TYR is abolished by chaotropic
treatment
Mantle,

(Houslay & Tipton,

1976),

19735 Tipton, Houslay &

Eluting a solubilized enzyme from DEAE-

cellulose with Triton X-100 also caused a loss of the
selective response to inhibitors

(Houslay & Tipton,

1975).

MAO activity became less sensitive to clorgyline and
more sensitive to deprenyl,

suggesting a loss of MAO A

activity by delipidation,
Youdim studied the inhibition of the multiple electro¬
phoretic forms of rat liver MAO by clorgyline.

Clorgyline

inhibition of both DA and KYN oxidation was Inversely
related

to mobility

(Youdim,

Holzbauer & Woods, 197^).

Coupled with the inverse relation of mobility to phospho¬
lipid content,

the idea arises that the absence of lipid

decreases clorgyline sensitivity,
be the case in cat brain MAO
Williams and Lawson studied
propargylamines,

Youdim found

this to

(Youdim & Holzbauer,

1976),

the class of compounds,

of which clorgyline is a member, and

'
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found that inhibitor potency correlated with lipophiliclty
(Williams & Lawson,
Theoretically,

1975).

lipids could account for multiple

activities in one protein by stabilizing one active site
versus another,

or,

one configuration of the site versus

another configuration.
MAO,

If the second ease were true in

one would expect the transformation of the A activity

into B activity upon delipidation with an increase in
activity to B form substrates,

Ekstedt and (Ireland tested

this using delipidated rat liver mitochondrial membranes
with MAO still bound

(Ekstedt & Oreland,

B-type activity was recovered completely,
was retained.

1975). The
but no A-type

When the B-form was Inhibited with deprenyl

before delipidation, and the membrane-bound MAO then
extracted,

no MAO activity was observed,

activity was produced

Thus no B

from transformation of A-type

activity by delipidation.

On the other hand,

clorgyllne

pretreatment had no effect on MAO B activity.
White and Glassman applied a variety of approaches to
elucidate the effects of solubilization techniques on the
microenvironment of MAO.

The properties of MAO in intact

mitochondria were compared

to MAO solubilized with a 30-

50.^ yield by 3$ Triton X-100,
either deprenyl or clorgyllne,

With low concentrations of
it was possible to selectively

determine the Michaells constants of substrates to each

type of MAO activity.
of 5raHT‘or PSA and
were similar.

Solubilization did not change the Km's

the ratio of activities to the substrates

The sensitivity fco inhibitors was unchanged

and biphasic curves to common substrates were preserved
(White & Classman,

1977).

Therefore both types of MAO

activity were relatively intact after solubilization.
Double-labelled mixed-substrate experiments can assess
Type A and Type B activity in the same incubation mixture.
In intact human brain mitochondria9

PEA and 5~HT are

oxidized

suggesting at least

independent of each other,

two active sites corresponding to MAO A and MAO B
Wu,

1975)«

(White &

It was not possible to separate the activities

by molecular size using gel filtration,

or by differences

In net surface charge as determined by electrofocusing.
These results indicate that different MAO sites could be
part of the same macromolecule

(White & C-lassman,

1977).

A variety of treatments were found to preferentially
inactivate 5“HT oxidation without affecting PEA MAO
activity.

Solubilization itself caused a slight decrease

in the 5~HT

t

PEA activity ratio.

ionic detergent, and
and

Incubation In SDS, an

sonication decreased MAO A activity

inhibitor selectivity. At low concentrations,

sulfhydryl

reagent caused a selective A-site inhibition in both MAO
preparations,
PEA,

preventable by high levels of 5-HT

Thiols and anionic phospholipids

, but not

could protect -the.

A-site in the solubilized MAO

from inactivation by

either high salt concentrations or prolonged
without substrate

(White Sc Glass'man,

incubation

1977).

The significance of this work lies in its presentation
of evidence for two independent active sites resulting
from differences in both protein conformation and lipid
environment.

The A-site has easily oxidized

moieties, and
bations.

sulfhydryl

is highly susceptible to membrane pertur¬

Veryovkina was able to inhibit MO A activity to
c;

5-HT by blocking 3 sulfhydryl groups per 1 x 10"' grams of
protein, while E-site inhibition required the blocking of
5 groups

(Veryovkina, Abdel Gamed & Gorkin,

1972),

Houslay prepared a model to test the role of lipids
in the selectivity of clorgylin and deprenyl.
Ca

2+

-Mg

2+

Pure

ATP-ase from rabbit sarcoplasmic reticulum can

be prepared

in various lipid bilayers to give protein

surrounded by a phospholipid annulus.
components,

By choosing the

one can provide either a fluid or rigid lipid

microenvironment for the enzyme at a given temperature.
The activity of the ATP-ase Is lowest at temperatures
that make the lipid annulus rigid, and
fluid lipid environments.

is maximum in

The effects of molecules on the

fluidity/rigidity of the annulus can be sensitively monitered
by changes in ATP-ase activity.
At temperatures that force a rigid annulus of the

phospholipids dimyrlstoyl lecithin (DML) and dipalmltoyl
lecithin (DPL),

clorgyline and deprenyl were able to

activate the ATP-ase} while increasing bilayer fluidity.
Dose-response curves revealed that clorgyline affected
activation and

fluidization at concentrations two orders

of magnitude less than deprenyl.

The difference in potency

could not be explained by the small differences in the
partition coefficients for the drugs

(Houslay,

1977),

This model suggests that the inhibitor selectivity is
not a protein-mediated event, but stems from the differing
potencies for lipid perturbation. As clorgyline is a
Type A inhibitors

the model supports the hypothesis that

the A-slte is more lipid-dependent for Its activity,
Huang,

Eiduson and SHih introduced the use of electron

spin resonance

(ESR)

p-hydroxyamphetamine

techniques to study MAO,

Spin-labelled

(SHA), a reversible MO inhibitor,

was used as a probe of the activity of a partially
purified
Shih,

,

solubilized rat brain MAO

(Huang,

Eiduson &

1976).

A characteristic signal is quenched when SHA is bound
to the enzyme.

The change in signal is proportional to

changes in the enzyme-inhibitor complex,
of enzyme-probe and

so quantification

enzyme-substrate interactions is

possible.
When SHA concentration was plotted against enzyme-Inhibitor
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concentration*

the probe was found

to bind

to MO in a

triphasic curve,felt to represent three different affinity
sites for SHA in the non-homogenous enzyme preparation.
ESR is particularly good
of an enzyme in situ.

for studying the active site

Huang and Elduson identified and

characterized three binding sites by intensive and extensive
parameters

(Huang & Elduson*

1977)*

Each binding site has a specific affinity that Is a
function of temperature according to the Gibbs-Helmholtz
relationship

t

d In K

where &H° is the apparent heat of formation of the site-SHA
complex; K is the apparent association constant;
gas constant,

and T is temperature.

R is the

The slope of InfK

versus - will give the heat of formation (aH°) at each
T
binding site.
When In K was plotted against 1/T,

three straight lines

of different slopes were observed,

characterizing three

distinct binding groups -e<,p , # .

The intersection of the

lines reflect the temperature at x^hlch one site predominates
over another*

called the transition temperature.

The

transition temperature is associated with changes in the
lipid domain of biomembranes that have been found to
correlate with changes in the functional activity of
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membrane-bound proteins.
Pretreatment with clorgyline and deprenyl caused prefer¬
ential Inhibition of the binding sites,
clorgyline and {3 left after deprenyl.

withe* left after

This,"-supports the

concept of two sites differing in lipid microenvironment,
The A site seems to be composed of |3 and
composed of (X and

Y

# , and

That both sites share

the B site

supports

the data that- 5“HT and PEAcan be substrates at either site.
The role played by the lipid microenvironment of MAO in
the intact mitochondrial outer membrane In the generation
of substrate specific forms is of vital clinical importance.
Any change of enzyme activity found to correlate with a
specific clinical state could be interpreted

in terms of

either a change in environment or a change In MAO protein.
Alternatively,

changes in activity due

might go unnoticed
purified9

fco membrane alterations

if MAO studies are performed only on

solubilized enzyme.

4 °i
IN_yiVO EVIDENCE

The impetus for the study of the multiple forms of
MAO originated
selective or

in the hope that development of substrate-

tissue-selective inhibitors would lead to

more useful tools for neurochemical research and to safe,
clinically helpful psychotropic drugs.
therefore,

It was necessary,

to study the effects of MAO Inhibitors In

vivo,
Collins,

Sandler and Youdlm compared

the in vitro

inhibition of the five bands of electrophoretically
separable rat liver MAO,

to inhibition of the same bands

from rats pretreated with intrapelfconeal injections of
tranylcypromine,
Youdim

&

Sandler,

pargyline and ciorgyllne

(Collins,

1972).

The In vitro sensitivity of the bands to Inhibitors
varied widely with no correlation to the binary classifi¬
cation of Johnston.

While distinct variation in the

inhibition of the bands was found

In vivo,

these variations

did not correlate with the apparent K^’s of each inhibitor
to each band as determined
The authors interpreted

in vitro.
their results as evidence for the

the in vivo significance of the electrophoretlcally generated
forms of MO,

postulating that If the forms were artefactual,

It might be expected
to the same extent.

that all forms would be inhibited
Clearly,

later research has proven the

role played by phospholipids, Triton X-100 and NTZ staining

so

in the generation of these forms,
Yang and Neff demonstrated
classified

that rat brain MO can be

into the A/3 system.

Each type is responsible

for the metabolism of different amines and can be preferentially blocked

(Yang & Neff,

197^).

Intravenous clorgyline gave an increase in brain 5“HT,
NE and DA with a concomitant decrease in 5"HIAA and
3,4—<3ihydroxyphenylaoetic acid
effect on 5~HT or NE,

(DOPAC).

Deprenyl had no

but there was a significant increase

in brain DA and decrease of DOPAC,

Thus DA appears to be

a substrate for both MO A and'TB. This was substantiated
both by blphaslc inhibition curves to clorgyline and
deprenyl in vitro, and by the observation that DA levels
were greatest in the brain after pretreatment with both
inhibitors.
The in vivo results correlated with the in vitro esti¬
mation of MAO inhibition using homogenized brain from
pre-treated rats.

The metabolism of Injected PEA was

found to be decreased by deprenyl, while unaffected by
clorgyline.
Roth and Gillis elegantly confirmed
using perfused rabbit lungs.

This system permits the

accurate measurement of Inhibitor,
concentrations.

Consequently,

these findings

substrate and metabolite

the pharmacokinetic problems

of drug metabolism and distribution Inherent in intact
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animal studies are avoided while maintaining the advantage
of an intact cell preparation (Roth & Glllis,

1975).

Roth and Qillis performed a douple-labelled mixedsubstrate experiment with equimolar concentrations of

3

H -5-HT and G

l4

-PEA perfused through the same lung and

observed no competition of oxidation.

The addition of

harinaline „ a reversible MO A inhibitor ,
decreased

selectively

5-HT oxidation without affecting activity to

PEA.the results substantiate the in vivo significance
of two separate enzyme activities.
The role of Type A and Type B MAO in the in vivo
regulation of biogenic amines was studied using specific
behavioral syndromes in the rat caused by increased
synaptic 5=,HT and DA respectively.
Green and Youdim reported

that the $~HT hyperactivity

syndrome produced by tranylcypromine
and

(MAO A and B inhibitor)

tryptophan load could not be Induced by tryptophan

loading and clorgyline pretreatment.

The doses of clorgyline

were shown to give 100$ inhibition of 5“HT MAO activity
in vitro.

It was necessary to achieve 100$ Inhibition of

both MAO A and 3 with clorgyline and deprenyl before the
5-HT behavioral syndrome could be induced by a tryptophan
load.

Clorgyline and tryptophan did not elevate brain 5-HT

to the levels found after tranylcypromine or clorgyline +
deprenyl

(Green

& Youdim,

1975). Analogous findings for

the behavioral syndrome produced by increased functional
DA in the rat brain were reported
& Youdim,

(Green,

Mitchell, Tordoff

1977). These authors found that the recovery of

Type A MO activity was 4,5 days and of Type B was 8,5
days.

The rate of recovery from irreversible inhibition

is generally thought to reflect the rate of new synthesis
of enzyme.

While the two forms seem to be under different

regulation, one cannot discriminate 'among, the alternatives
of new protein synthesis, renewal of lipid moiety attach¬
ment,

or different rates of specific mitochondrial

regeneration,
Nonetheless,the experiments show that both 5“HT and DA
can be metabolized by both types of MO in vivo.

It is

possible that MO A and B function as an integrated unit
In the same cell

(HousXay, Tipton & Youdim,

1976),

Pathological states could arise from an imbalance between
the two forms at a specific

site.

HU MM PLATELET MO

The discovery of significant MAO activity in the human
platelet is of particular significance for neuropsychiatrl
research,
for study.

primarily due to the ease of obtaining samples
Platelet MO can be helpful both diagnostically

to characterize certain disorders, and

therapeutically to

assess the efficacy of drugs purported

to act via altera¬

tions in MAO.

Naturally,

the degree of similarity between

platelet MAO and MAO from other tissues,

especially the

brain must be determined.
Robinson compared rat liver to human platelet MAO
activity towards BZ,

TYR, TRIP and

5-HT.

Though the

specific activity was greater in rat liver,

the rank order

was the same. The K, *s for BZ and TYR were virtually the
same,

but those for TRYP and

different.

5"HT were significantly

Rat liver and human platelet MAO responded

equivalently to KAO inhibitors

(Robinson,

et,

al.,1968).

The authors felt the evidence pointed to similarities
between the KAO's,

though cross-species comparisons

difficult to assess.

are

Of more importance was the good

correlation found for the In vivo inhibition of platelet
MAO and urinary excretion of TRYP.

It appears platelet MAO

is responsible for the peripheral metabolism of some
biogenic amines,
Collins and

Sandler prepared a solubilized MAO from

human platelet mitochondria using two hours of sonication
in the presence of 1% Triton X™100 and gel filtration

53

through Scphadex G-200,

A single peak of enzyme activity

with MW-235»000 was obtained, representing a 12-fold

purif1ca11one though 90% of the original activity was
lost

(Collins & Sandler,

1971).

The relative activities

toward DA, TRYP, TYR, KYN and BZ did not change through
various steps in the purification.

A more labile form was

not felt to have been lost. Unfortunately,
nor NS,

neither 5-HT

substrates preferentially oxidized by MO A, were

tested .
The purified MAO showed a biphasic heat inactivation
curve not apparant in MAO from lysed platelets,

suggesting

some change in the response to physical factors. The
kinetic constants of substrates and

inhibitors were in

good agreement with those obtained by Robinson (Robinson,
et „ al,,

1968),

Polyacrylamide gel electrophoresis using NTZ staining
with TRYP as

substrate resulted

in a single band of activity.

It is interesting to speculate why the identical purifica¬
tion technique used by Youdim to prepare his multiple
forms in rat liver MAO yielded but one band

In the platelet.

This may reflect mitochondrial homogeneity in the platelet.
Amitriptyline, a tricyclic antidepressant:,
human platelet MAO in vitro

(Edwards & Burns,

effect was equivalent for platelet sonicates,
preparations and perchlorate-treated enzyme,

inhibits
197^). The
purified MAO
so the

inhibition was not due to membrane or lipid changes.
Amitriptyline inhibition is reversible
and PEA,

for BZ, TRIP

but the mechanism was competltve for BZ and

non-competitive for TRIP and PEA.

'

The difference in

kinetics led to the proposal that platelet MAO has two
catalytic sites,- one for BZ and another for TRYP and PEA,
Mixed-substrate experiments revealed that BZ and TRYP
were mutually competitive, with PEA mutually non-corapetitive
with BZ and TRYP.

These results imply that BZ and TRYP

share a site with another for PEA (Edwards & Chang, 1975).
It is difficult to reconcile the two experiments with
respect to inhibition of TRYP MAO activity.
Amitriptyline inhibition of platelet MAO was replicated
in MAO B from human brain (Roth,

1976),

When mixed-substrate

experiments for BZ and PEA and MAO inhibition by amitrip¬
tyline were performed at high Op concentrations, all
inhibition was found

to be competitive.

levels amitriptyline,

Thus, at high Op

BZ and PEA seemed to Interact at

one site,
The effect of 0^ is interpretable interms of the
reaction mechanism.
mechanism (Tipton,

MAO possesses a "ping-pong" kinetic
1972j Yasunobu & Oi,

by a two-step reaction*

1972), as summarized

(1)

E - F -i- RCH2NH2->EA
E

+

A

E’P1P2~> E-FH2 + NH^ * RCHO
'

E*

P„ +
P
1
2
Reduction of Flavin cofactor

Deamination of Amine

(2)

+

E*»Fh2 + 02~^ E'B --> EQ -* E~F + H2C>2
Reoxidatlon of flavin by oxygen

In such reactions, as the 02 concentration decreases,
the affinity for the substrate A increases

{Tipton,

1972),

protecting the reaction against variations in the C*2 level
of its environment.

The

for 02 is about 0.250 mM,

equivalent to the concentration of dissolved

02 in

air»»satinvited water at physiological temperatures.
in vivo and
02.

in assay media,

Consequently,

- Both

MAO will not be saturated by

the overall rate of reaction is dependent

on the concentration and K

m

of both 0o and
2

the substrate.

By raising the concentration of 02 to super-physiological
levels,

Roth was able to saturate MAO and effectively keep

it in the oxidized

form.

The deaminating step became

rate-limiting so the competition between substrate and
inhibitor could be observed.
revealed

the theoretically expected

inhibition of BZ,
oxidized

Kinetic analysis of the data
linear competitive

PEA and amitriptyline at one site on the

form of MO

(Roth,

1976).

These results indicate that mixed-substrate and

inhibitor

experiments interpreted as evidence for multiple sites or
forms must take into account the oxidative state of MAO.
An inhibitor binding to either E or E' will give competitive
or uncompetitive inhibition respectively.

Non-competitive

inhibition results from binding to both forms of the enzyme
(Piszkiewlcz*
the oxidized
reduced

1977).

In the case of MAO,

form of the enzyme, and E5

E corresponds to
corresponds to the

form.

It is likely that both KAO A and B will exist in two
conformations,

one oxidized

(E), and one reduced.

(E’)>

Binding to Es with lowered affinity at high inhibitor
concentrations

(i,e,

second

substrate or inhibitor like

amitriptyline), will produce the hyperbolic replot data
observed

in the human platelet

and human brain (Roth,

1976).

(Edwards & Burns,

197*0

The non-competitive kinetics

result from both the decreased affinity to E*, and
decreased rate of product formation.

Possibly,

the

the two'

conformations of platelet MAO reported by Kebayashi and
Eiduson reflect change's In the oxidative state
Eiduson,

(Kobayashi &

1977).

Donnelly and Murphy utilized kinetic and

inhibitor

studies to characterize human platelet MAO as Type B.
was prepared

MAO

by short sonication and freeze-thaw without

attempts to purify and delipidate. The loss of labile or
lipid-dependent forms is probably not a problem (Donnelly &
Murphy,

1977).

S7

Essentially 100% of MO activity to TYR,
PEA and BZ was Inhibited
1x10

M clorgyline and

no inhibition.

by 1x10

-6

DA, TRYP,

M deprenyl, while

30 minute prelncubatlon caused

Both inhibitors gave single sigmoidal

curves for common and B-slte substrates.

The K

*s for PEA

and TRYP in the platelet are in agreement with those
reported for human brain and liver M0
197?).

(White & Classman,

The evidence that platelet MO corresponds to Type

B very similar to MO B found
especially the brain,

in other human tissues,

is quite strong.

The homogeneity of human platelet MO has particular
significance for the question of enzyme multiplicity.
Differential proportions of M0 A to MAO B have been shown
to exist in many tissues of various species,
preparations are exclusive for either type
Achee,
Tipton,

Gabay & Tipton,
1978),

1977l Fowler,

though few

(for reviews,

Callingham,

Mantle &

Among these experiments of nature are

tissue culture preparations of rat C6 glial cells and
mouse neuroblastoma N1E-115 cells,
Richelson &. Murphy,

both MO A,(Donnelly,

1976),and the human platelet. The

discovery of a pure Type A human cell would afford the
opportunity to determine the molecular basis of the.-i
distinction between MO activities.

CLINICAL STUDY}

MO AND PRIMARY
CHILDHOOD AUTISM

INTRODUCTION

Neuropsychiatric research on platelet MO has been
spurred by the repeated
in adu.lt>

chronic

Meltzer & Stahl,

finding of reduced MAO activity

schizophrenia
197^;

Sullivan,

and bipolar depressive illness
Leckman,

Gershon,

(Murphy & Wyatt,

1976;

Owen,

Stanfield & Dackis,

(Murphy & Weiss,

Nichols & Murphy,

this topic is far from complete
Bourne,

Crow,

Correspondence section,

et.

1972;

1977).

(White,

al.,

1972;

Consensus on

Mcleod & Davidson,

1976;

New England J,

1977),

especially the

of Med.

298(20)11150).

Family and twin studies have suggested that reduced platelet
Mo activity may be a biological marker for vulnerability
to psychiatric disorders
Coursey & Murphy,

(Wyatt,

et.

al.,

1973; Buchsbaum,

197 6).

Comparison of the properties of platelets and

serotonergic

synaptosomes suggest that the platelet can serve as a model
for the transport,

storage,

by CNS serotonergic neurons
Stahl,

1977).

of neurons

metabolism and release of 5“HT
(Pletscher,

I960;

Sneddon,

1973;

MO plays a; role In the uptake- of - monoamines

(Trendelenburg,

1972)

by altering their intra¬

cellular concentrations. This has not been studied as yet
In the platelet,

though it could help explain the elevated

levels of 5~HT reported
(Hanley,

in a subgroup of autistic ehidren

Stahl & Freedman,

1977).

Primary childhood autism is a syndrome manifested
during the first two years of life by disturbances in social,
emotional and cognitive development

(Rutter,1974) .

The aim

of this study is to explore MAO activity in autistic
children and

their families to determine the occurence of

a subgroup who either have variant levels of activity
against normals,

or arc variant in relation to their

family,

SUBJECTS AND METHODS

POPULATION
Twenty children

(18 boys,

two girls) with early child¬

hood autism were the subjects of this investigation.
ranged

in ago from 4 to 23 years

They

(mean=12.8 years).

Nine

children were unmedicated,

six were on one drug and

five

were taking more than one.

Aside from vitamins and anti¬

histamines, medications included neuroleptics and anti¬
convulsant s .
All children satisfied the diagnostic criteria for
primary childhood autism5

onset of symptoms of develop¬

mental disability before two years of age; absence or
marked limitation of social relatedness;
delay and

Idiosyncrasies; need

movement disturbances;

profound language

for environmental stability;

islets of better functioning;

relatively normal motor landmarks.

60

Control subjects

(15 Rials,'

5

female) consisted of

children (8 less than 15 years) and adults with no personal
medical or psychiatric disturbances and no known family
history of autism, aphasia,

or other developmental

disturbances.
Platelet MO was assayed in the parents and normal

Ar

sibllngs of nine children with autism to study the genetic
contribution to MAO activity in these children.

METHOD
Consent was obtained

from all participating individuals

after explaining the purposes,
study.

procedures and risks of the

Samples of blood for MAO assay from the index

children were obtained as part of a broader initial eval¬
uation and at subsequent occasions when the clinical
indications for venipuncture were present.
Blood was obtained via standard venipuncture, using
a 21-guage,

siliconized needle, and collected

in glass

tubes containing 10.5 mg of EDTA, The blood was immediately
placed on ice,-Within three hours of collection,

the platelets

were harvested by centrifugation in succession at 175 and
300 g,

each for ten minutes, and 4,000 g for twenty minutes

to isolate the platelets.
cold

Platelets were washed

in 2 ml of

isotonic saline, reisolated by centrifugation, and

stored as a pellet frozen for a maximum of two weeks.

Platelets disrupted by sonication were incubated

in the

presence of 1,67 x 10^H Tyramine labelled with

in a

total of 1.5 21I of 0,05 M potassium phosphate buffer,
pH 7.4.
Lowry

Platelet protein was assayed by the method of

(Lowry,

et.

al.,1951), and platelet MAC was reported

as nanamoles of deaminated product formed per milligram
of platelet protein per 60 minutes of incubation (Roth,
et,

al.,

1976),

RESULTS

Analysis of MAO activity correlation to age was not
significant for the entire population of patients,
members of afflicted children and

index patients.

of correlation was maintained for autistlcs,

family
The lack

male aucistics,

family members alone, normals alone, and normals discriminated
by sex.

Sex differences revealed women (mean,:29.322) to

have a significantly higher activity than males
Group means for normal males,

(mean,19.401).

male autlstics and male

family members were not slgnificantly different.

The sample

size for autistic females was too small for adequate statis¬
tical analysis

(Table 1).

Thereywas no significant difference

between autistic males and normal males less than 24 years
old

(Table 2).

MAO activity for normal males appeared

be normally distributed,

to

though the distribution for male

Cl

autistics was not as clearcut

(Figure 1).

MO levels were assayed for parents,
and

index children in nine families

normal siblings

(Fig.2),

Analysis of

variance showed no significant clustering of MAO activity
by family

(F=1,313 , NS),

DISCUSSION

Normative data to assess the relative contributions
of age and

sex on platelet MAO activity has been accumulated.

Using BZ as a substrate, Robinson has studied a total of
71 men and 91 women,
1971s Robinson,

21

1975).

to 84 years of age

al,,

He found a significant correlation

with age in both populations, and
higher MAO activity.

(Robinson,et.

that females have 27%

It should be noted that the increase

in activity is most pronounced after the age of 55»

especially

In women. A study of 680 normals through the age of 60 did
not reveal any correlation with age in either sex,
females had activities 20%> higher than males

though

(Murphy,

Wright,

et. al.,

1976). The frequency distribution significantly

deviated

from normal,

resulting from a skewing of the curve

by a few high values and more low values than expected.
Statistical tests failed to reveal a bimodal distribution
Roth,
children,

Young and Cohen extended the normative data to
with an eye to any influence of puberty on MAO

6>3

activity

(Roth* Young & Cohen,

1976), The variability of

MAO activity was 17.7% for all children,
30% for females and

only 10% for males.

between age and activity was found
years.

though it was
No correlation

through the age of 40

Females were found to have 2J% higher activity at
Prepubescent and pubescent females had $2% and

all ages,

6lfo greater activity respectively. There was a significant
decrease in activity in post-pubertal females.

Nothing in

the present study is in disagreement with the data previously
reported.
This study corroborates previously reported work on MAO
activity in autistic children (Boullin,
Cambell,

et.al.,1975*

et, al,,19765 Cohen, Young & Roth,

Ziegler & Murphy,
from normals.

1977)

1977? Lake,

showing no difference in activity

The non-signifleant analysis of variance for

activity in families reported here does not agree with the
results of Cohen (Fig.25 Cohen, Young & Roth,1977).
included

two normal families in his study, and

Cohen

it is con¬

ceivable that the significant clustering he reported
reflects a difference between normal and autistic families.
It appears that MAO does not contribute to the elevated
5-HT found

in some autistic children.

Simultaneous measure¬

ments of 5~HT and MAO would be most illuminating.

'

- •

‘ --

Table 1.- Group Means for Males

Platelet MAO Activity
nmoles/ mg protein/ hr.
Normal

Autistic

19,401+ 9.173

Family Member

P

24.814+ 10,585
it

it -X- ■If it it -S- it-

NS

(N = 18)

(N = 15)....
19.401+ 9.173

22,974+8,459
NS
(N =' 12)

(N = 15)
24.814+10.585

NS

22.974+8.459

Table 2.-Group means for Males,

24 years

Platelet MAO Activity
nmoles/ mg protein/ hr

AUTISTIC

23,133?±9.033

24.8418+10.551

f!
00

NORMAL

__ 1N_je_1£1_

2

r'

P
NS
.

1,~ Distribution of MAO activity In Normal & Autistic Males

FREQUENCY

Fig*.

MAO ACTIVITY (nmoles/mg prot/hr)

64

FAMILY
Fig.

2.

Platelet MAO activity grouped by families.
For familial clustering, F-l.3^3* P~NS
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